Tafolecimab: First Approval

This article summarizes the milestones in the development of tafolecimab leading to this first approval for the treatment of adults with primary hyperlipidemia and mixed dyslipidemia.

http://link.springer.com/10.1007/s40265-023-01952-y

Source: Drugs - October 17, 2023 Category: Drugs & Pharmacology Source Type: research